Yvonne Tsitsiou

Yvonne Tsitsiou

Auto-generated profile, based on publicly available information

Yvonne Tsitsiou

Imperial College Healthcare NHS Trust, London, UK; Imperial College Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2023 in CardioVascular and Interventional Radiology
Verified
Journal Article
Open access
PDF file
YTYvonne Tsitsiou
Yvonne Tsitsiou
BVBar Velan
Bar Velan
RRRebecca Ross
Rebecca Ross
RLRaghu Lakshminarayan
Raghu Lakshminarayan
ARAndy Rogers
Andy Rogers
MHMohamad Hamady
Mohamad Hamady
Purpose: Endovascular aortic repair (EAR) interventions, endovascular abdominal aortic repair (EVAR) and thoracic endovascular aortic repair (TEVAR), are associated with significant radiation exposures. We aimed to investigate the radiation doses from real-world practice and propose diagnostic reference level (DRL) for the UK. Materials and Methods: Radiation data and essential demographics were retrospectively collected from 24 vascular and interventional radiology centres in the UK for all patients undergoing EAR—standard EVAR or complex, branched/fenestrated (BEVAR/FEVAR), and TEVAR—between 2018 and 2021. The data set was further categorised according to X-ray unit type, either fixed or mobile. The proposed national DRL is the 75th percentile of the collective medians for procedure KAP (kerma area product), cumulative air kerma (CAK), fluoroscopy KAP and CAK. Results: Data from 3712 endovascular aortic procedures were collected, including 2062 cases were standard EVAR, 906 cases of BEVAR/FEVAR and 509 cases of TEVAR. The majority of endovascular procedures (3477/3712) were performed on fixed X-ray units. The proposed DRL for KAP was 162 Gy cm2, 175 Gy cm2 and 266 Gy cm2 for standard EVAR, TEVAR and BEVAR/FEVAR, respectively. Conclusion: The development of DRLs is pertinent to EAR procedures as the first step to optimise the radiation risks to patients and staff while maintaining the highest patient care and paving the way for steps to reduce radiation exposures.

1 January 2025 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
SCSelina Chiu
Selina Chiu
YTYvonne Tsitsiou
Yvonne Tsitsiou
ASAndrea Da Silva
Andrea Da Silva
CQCathy Qin
Cathy Qin
CFChristina Fotopoulou
Christina Fotopoulou
ARAnd Andrea G. Rockall
And Andrea G. Rockall
Chiu S, et al. Korean J Radiol. 2025 Jul;26:e64. https://doi.org/10.3348/kjr.2025.0357

12 December 2023 in CardioVascular and Interventional Radiology
Verified
Journal Article
Open access
PDF file
YTYvonne Tsitsiou
Yvonne Tsitsiou
BVBar Velan
Bar Velan
RRRebecca Ross
Rebecca Ross
RLRaghu Lakshminarayan
Raghu Lakshminarayan
ARAndy Rogers
Andy Rogers
MHMohamad Hamady
Mohamad Hamady

6 September 2022 in Journal of Medical Imaging and Radiation Sciences
Verified
Journal Article
Open access
YTYvonne Tsitsiou
Yvonne Tsitsiou
LRLeisha Rajkumar
Leisha Rajkumar
LHLinda Tebogo Hlabangana
Linda Tebogo Hlabangana
JNJaishree Naidoo
Jaishree Naidoo
LCLizelle Mary Clark
Lizelle Mary Clark
SASavvas Andronikou
Savvas Andronikou
Lateral chest radiographs aid in paediatric clinical practice in countries where the diagnosis of primary pulmonary tuberculosis (PTB) still relies heavily on the chest radiograph. This study aimed to create a validated quality assurance (QA) tool investigating the diagnostic performance of this projection by applying this to a database of lateral chest radiographs in children with suspected PTB. The QA tool was built to include a compilation of criteria from the different sources, accompanied by graphic representations and objective measurements where appropriate. Each defined criterion (radiographic error) was evaluated by implementing the QA tool on 300 radiographs, scored by three readers. The sample was subjected to two separate sets of data analysis, based on averages, and on majority decision methodology. The QA tool was based on existing published criteria, as well as under-collimation and under-inspiration, two de novo criteria. For the total 900 reads, errors were categorized as patient-related in 681 (75.7%) and radiographer-related in 421 (46.8%) and 122 (13.6%) had no errors. The average number of errors per radiograph ranged from 0.9 to 4.7 errors out of the 11 quality factors reviewed. When considering the majority decision, the median errors per radiograph was 1 (IQR 1-2) (range 0-5). Inter-rater agreement varied for different criteria. A novel QA tool for evaluating lateral chest radiographs was developed which requires further efforts of refinement regarding criteria such as exposure, field of view: under-collimation, and motion artifact, which remain subjective. The designed QA tool will allow comparison of radiograph quality before and after interventions. Furthermore, the tool can be used in tackling childhood PTB in low- and middle-income countries (LMICs) since the hallmark of the disease is lymphadenopathy, which is often depicted best on lateral chest radiographs.

2 April 2026 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Open access
YTYvonne Tsitsiou
Yvonne Tsitsiou
KCKaranjot Chhatwal
Karanjot Chhatwal
YAYusuf Alghabra
Yusuf Alghabra
SASammy Arab
Sammy Arab
ACAndreaa Cuciuc
Andreaa Cuciuc
ADAlun Davies
Alun Davies
This systematic review aimed to evaluate the clinical effectiveness of duplex ultrasound (DUS) surveillance following infra-inguinal revascularisation, both surgical and endovascular, in patients with intermittent claudication (IC) or chronic limb threatening ischaemia (CLTI). Ovid MEDLINE, Embase, and Cochrane Library. A systematic search of MEDLINE, Embase, and the Cochrane Library was conducted from inception to 1 June 2024, following PRISMA guidelines. Studies were eligible if they reported DUS surveillance protocols after infra-inguinal revascularisation and included clinical outcomes such as patency, re-intervention, amputation, or death. Randomised controlled trials (RCTs) and observational studies were included. Risk of bias was assessed using RoB 2 and ROBINS-I tools. Following an a priori methodological plan, meta-analysis was not attempted because studies were not sufficiently comparable. Sixty-one studies were included, with 77% evaluating surgical revascularisation and 23% evaluating endovascular. DUS surveillance following surgery was associated with improved primary assisted patency in 70% of studies and lower amputation rates in several comparative studies. One RCT showed no significant benefit, highlighting heterogeneity. Evidence for endovascular surveillance was limited but promising; two prospective comparative studies demonstrated improved patency, reduced amputations (7 - 10% vs. 35 - 50%), and lower mortality with DUS. Economic analyses reported reduced healthcare costs and amputations with DUS following surgical bypass. However, most studies were observational with moderate to high risk of bias, and DUS protocols varied widely in frequency and duration. In endovascular cohorts, benefits were most evident in studies including longer lesions. Where reported, amputation outcomes are presented separately for CLTI and IC. DUS surveillance appears to improve patency and limb salvage following surgical revascularisation and may reduce healthcare costs. Emerging evidence suggests potential benefits in endovascular cases, particularly for long lesions. High quality multicentre RCTs and economic evaluations are needed to determine the optimal surveillance strategy and to inform standardised clinical guidelines.